ReviewCancer management and research2019

Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis.

Yiqun Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.